Clinical Trials Logo

Clinical Trial Summary

The goal of this trial to see if repetitive transcranial magnetic stimulation (rTMS) to the hearing area of the brain can lessen the perception of tinnitus. rTMS uses a strong magnet and when placed against the scalp generates a small electrical field within the brain. Depending on the frequency of the stimulation, this electrical field can either decrease or increase the electrical excitability of the brain. In this study, low-frequency stimulation will be used, which is thought to decrease nerve activity. It is this electrical excitability of the brain that is thought to be responsible for tinnitus.

The hypothesis of this study is that rTMS can decrease the perception of tinnitus.


Clinical Trial Description

This will be a cross-over randomized trial. The order of the treatments received will be randomly selected and the participant will not be told which treatment they are receiving. Subjects will fall into one of the four treatment groups described below:

1. 2 weeks of active rTMS treatment followed by washout and then by 2 weeks sham

2. 2 weeks of sham followed by washout and then 2 weeks of active rTMS treatment

3. 4 weeks of active rTMS treatment followed by washout and then 4 weeks of sham

4. 4 weeks of sham followed by washout and then 4 weeks of active rTMS treatment

For the washout period between the two interventions, we will plan a minimum of 2 weeks to avoid the problem of carryover effects. Prior to starting the next intervention after the washout period, we will re-assess subject's tinnitus severity. To ensure no carryover effect, the washout period will be extended for those subjects whose tinnitus severity, as defined by the THI, is more than 20 points different than their baseline THI score. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00567892
Study type Interventional
Source Washington University School of Medicine
Contact
Status Completed
Phase Phase 2
Start date January 2008
Completion date June 2011

See also
  Status Clinical Trial Phase
Completed NCT00955799 - Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus Phase 3
Completed NCT00739635 - Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus Phase 3
Completed NCT03550430 - Neurofeedback for Tinnitus - Does Frequency Specificity Matter? N/A
Completed NCT00772980 - Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus Phase 3
Completed NCT04829214 - OTO-313 in Subjects With Unilateral Subjective Tinnitus Phase 2
Completed NCT01268449 - Evaluation of Low Dose Laser in Treatment of Tinnitus Phase 2
Completed NCT01177137 - Tinnitus Retraining Therapy Trial Phase 3
Terminated NCT00827008 - Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus Phase 3
Unknown status NCT00555776 - Effect of Gabapentin on Idiopathic Subjective Tinnitus Phase 2
Completed NCT05265949 - The Effects of Weight Loss on Tinnitus Symptoms N/A
Completed NCT04696588 - Neck Kinesiotherapy and Massage in Tinnitus Treatment N/A